Kemal Karaagac/LinkedIn
Oct 3, 2026, 05:52
Kemal Karaagac: When Vitamin K Antagonists Remain Essential in Cardiac Care
Kemal Karaagac, Cardiologist at Cihangir Hospital, shared a post on X about a recent article by Eva Kempers et al., published in Heart, adding:
“VKAs remain essential when DOACs are unsuitable or their benefit is uncertain, including mechanical valves, AF with moderate-to-severe mitral stenosis, thrombi, and some frail older patients. Despite DOAC advances, VKA therapy remains vital in selected patients.”
Title: Timeless therapeutics: cardiac indications for vitamin K antagonists in clinical practice
Authors: Eva K. Kempers, Melanie Jacqueline J. Acampo-de Jong, Hugo ten Cate, Raffaele De Caterina, Marieke J. H. A. Kruip
Stay updated on all scientific advances with Hemostasis Today.
Anticoagulation
Atrial Fibrillation
cardiac thrombi
Cardiology
DOACs
Eva K Kempers
Frailty
Heart
Hemostasis News
Hemostasis Today
Hugo ten Cate
Kemal Karaagac
Marieke J.H.A. Kruip
Mechanical Heart Valves
Melanie Jacqueline J. Acampo-de Jong
Mitral Stenosis
Raffaele De Caterina
Vitamin K antagonists
VKAs
-
Oct 3, 2026, 15:49Behnood Bikdeli: COATED_AIR Trial Design Published as Enrollment Reaches 3,000 Patients
-
Oct 3, 2026, 15:25Vanrose Panashe Nyamangodo: A Multi-Task Deep Learning Model For Malaria And Anemia
-
Oct 3, 2026, 14:52Benny Sorensen: Glanzmann’s Thrombasthenia Finally Assigned Dedicated ICD-10 Code
-
Oct 3, 2026, 14:52The Real-World Burden Of DVT In Traumatic Fractures – ISTH
-
Oct 3, 2026, 14:41How Much Do We Really Know About The Global Burden Of Venous Thromboembolism? – World Thrombosis Day
-
Oct 3, 2026, 14:35Nnadozie Gabriel C.: Understanding Hemophilia – Modern Breakthroughs and the Gap in Global Access
-
Oct 3, 2026, 14:26Björn Mulder: Differentiating PRP Formulations and Cell Counts in Knee and Ankle OA
-
Oct 3, 2026, 14:25Jorge Enrique: Personalised Strategies for Thrombosis Management in Cancer-Associated Cases
-
Oct 3, 2026, 14:20James Fildes: A New Way To Study Device Thrombogenicity